Global Oncology Injectable Supplier from India
Cordium Pharmaceuticals Pvt Ltd is engaged in the international supply of high-quality Gemcitabine Injection (200mg / 1g / 2g) for regulated healthcare markets and institutional procurement networks.
The company specializes in oncology-grade sterile injectables, meeting the increasing global demand for reliable chemotherapy medicines across hospitals, cancer treatment centers, government tenders, and licensed import distributors.
High-Demand Product: Gemcitabine Injection Range
Gemcitabine is a widely used antineoplastic medication prescribed in oncology protocols. The product is available in multiple strengths to support diverse clinical requirements:
- Gemcitabine Injection 200mg – low-dose clinical applications
- Gemcitabine Injection 1g – standard oncology regimens
- Gemcitabine Injection 2g – hospital-grade bulk treatment cycles
Manufactured under strict sterile conditions, these formulations are developed to support global oncology treatment standards and export compliance requirements.
International Market Distribution
Cordium Pharmaceuticals Pvt Ltd supplies to a wide network of regulated and semi-regulated markets, including:
- United States – advanced oncology treatment demand
- Germany – high compliance healthcare systems
- United Kingdom – NHS and private oncology clinics
- Netherlands – EU pharma logistics gateway
- South Africa – growing oncology treatment access
- United Arab Emirates – premium hospital procurement
- Brazil – expanding oncology infrastructure
Why Global Buyers Prefer Indian Pharma Exporters
India continues to lead global pharmaceutical exports due to:
- Cost-efficient sterile manufacturing capabilities
- Strong WHO-GMP compliance systems
- Advanced oncology formulation expertise
- Scalable production for institutional demand
- Reliable international supply chain infrastructure
Cordium Pharmaceuticals Pvt Ltd leverages these strengths to deliver consistent oncology injectable supply worldwide.
Key Applications in Oncology Care
Gemcitabine Injection is widely integrated into hospital oncology protocols for:
- Solid tumor chemotherapy regimens
- Hospital-based cancer treatment cycles
- Combination therapy in oncology departments
- Specialist oncology clinic use under supervision
Export Strength & Supply Capability
Cordium Pharmaceuticals Pvt Ltd ensures seamless international distribution through:
- Bulk institutional packaging solutions
- Regulatory documentation support for exports
- Export-grade sterile vial handling
- Reliable global logistics coordination
- Flexible order fulfillment for hospitals & distributors
Ideal Buyers & Partners
This product is suitable for:
- Hospital procurement departments
- Oncology clinics and cancer institutes
- Licensed pharmaceutical importers
- International distributors & wholesalers
- Government healthcare tenders
- Personal import buyers (with valid prescription compliance)
Business Enquiry & Contact Details
For global sourcing, distributor partnerships, and bulk oncology injectable requirements:
📱 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
Cordium Pharmaceuticals Pvt Ltd is actively expanding its global oncology injectable supply network.
Disclaimer
This content is intended for pharmaceutical trade and informational use only. Gemcitabine is a prescription oncology medication and must be used strictly under qualified medical supervision according to local regulatory guidelines.